Company: VMCWF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001827
Chunk: 15

Company: Valuence Merger Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 15
---
 believes that we have the right in-house capabilities, sector expertise, and connectivity to identify and consummate a potential
Business Combination in our target geography within the aforementioned sectors.

Collaborative
Sourcing and Diligence Process

Our
sourcing process is expected to be enhanced by our collaboration with CrystalBioSciences Co., Ltd, a South Korean venture capital firm
(“CBS”), Credian Partners Inc., a private equity firm based in South Korea (“Credian”), and Quantum Leaps Corporation,
a Japan-based consulting firm (“Quantum Leaps”). We will make the best use of the unique sourcing and analytics capabilities
of CBS, Credian, and Quantum Leaps, leveraging a team of 12 professionals to support us in the identification and diligence of potential
targets for our initial Business Combination.

CBS
and its management team has participated in 15 strategic investments, including transactions completed through its parent CrystalGenomics,
Inc., a South Korean commercial-stage biopharmaceutical company (“CrystalGenomics”), and CBS has a deep bench of professionals
that has the ability to scope promising and scalable technologies. Credian also brings extensive sourcing capabilities that has led to
a strong track record with 21.5% cumulative IRR since inception to the consummation of the IPO.

Furthermore,
we will leverage Quantum Leaps to extend our sourcing and due diligence capabilities by working closely with them to strengthen our connectivity
within Japan and its current network.

In
addition to our internal proprietary sourcing process, collaboration with CBS, Credian, and Quantum Leaps, our sourcing efforts are expected
to be further supported by our board members.

11

Extensive
Diligence and Evaluation

Our
selection and diligence process will be supplemented by the management team’s M&A track record. After examining the quality
of a potential target’s management team and conducting extensive primary research into such target’s competitive differentiation,
market opportunities, product development roadmap, customer traction, sales strategy, and operating model, we expect to produce a range
of scenarios with a high level of quantitative rigor and attach strong supporting evidence for the assumptions driving each scenario.
We believe this deeper understanding of how the story is quantified into future growth and profitability is expected to help a potential
target to achieve a successful public listing, make better strategic decisions over time, and enable such target to better understand
the elements required to deliver strong shareholder returns.

Experienced
Team and Board of Directors

We
believe our Board of Directors and management team bring